Addiction and Pharmacology Research (APRL) Clinical Trials
APRL Main Page | Adult Clinical Trials Main Page
Further protocol information can be found on the links below at ClinicalTrials.gov
Active Trials
Title: A Pilot Trial of Naltrexone for Methamphetamine Addiction - Role of the A118G SNP
Description: Study of Naltrexone for Methamphetamine Addiction
Investigator: John Mendelson, MD
Eligibility: Males and Females ages 18-50 that use methamphetamine and want to quit
Status: Active and open to enrollment
Contact: Kathleen Garrison, 415-641-3370,
Email: GarrisD@cpmcri.org about Study Naltrexone
- updated May 2011
Back to top